IN8bio, Inc.INABNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
31.45%
↑ 151% above average
Average (28q)
-61.92%
Historical baseline
Range
High:54.47%
Low:-1764.66%
Volatility
-2938.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 31.45% |
| Q2 2025 | -1764.66% |
| Q1 2025 | 21.76% |
| Q4 2024 | 43.33% |
| Q3 2024 | 21.05% |
| Q2 2024 | 5.00% |
| Q1 2024 | 4.76% |
| Q4 2023 | 8.70% |
| Q3 2023 | 14.81% |
| Q2 2023 | 10.00% |
| Q1 2023 | 6.25% |
| Q4 2022 | 5.88% |
| Q3 2022 | 10.53% |
| Q2 2022 | -15.15% |
| Q1 2022 | -6.45% |
| Q4 2021 | -72.22% |
| Q3 2021 | -12.50% |
| Q2 2021 | -33.33% |
| Q1 2021 | 0.00% |
| Q4 2020 | -38.73% |
| Q3 2020 | 54.47% |
| Q2 2020 | -72.73% |
| Q1 2020 | -20.35% |
| Q4 2019 | 0.00% |
| Q3 2019 | 2.56% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |